» Articles » PMID: 2781282

Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor

Overview
Journal Science
Specialty Science
Date 1989 Sep 22
PMID 2781282
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

RU 486, a steroid with high affinity for the progesterone receptor, is the first available active antiprogesterone. It has been used successfully as a medical alternative for early pregnancy interruption, and it also has other potential applications in medicine and for biochemical and pathophysiological endocrine research.

Citing Articles

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available , , and Data.

Kay J, Brody J, Schwarzman M, Rudel R Environ Health Perspect. 2024; 132(1):17002.

PMID: 38197648 PMC: 10777819. DOI: 10.1289/EHP13233.


Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.

Elia A, Saldain L, Vanzulli S, Helguero L, Lamb C, Fabris V Clin Cancer Res. 2022; 29(5):866-877.

PMID: 36269797 PMC: 9975668. DOI: 10.1158/1078-0432.CCR-22-2060.


Multiple Components of Protein Homeostasis Pathway Can Be Targeted to Produce Drug Synergies with VCP Inhibitors in Ovarian Cancer.

Bastola P, Leiserowitz G, Chien J Cancers (Basel). 2022; 14(12).

PMID: 35740614 PMC: 9220887. DOI: 10.3390/cancers14122949.


Regulation by Progestins, Corticosteroids, and RU486 of Transcriptional Activation of Elephant Shark and Human Progesterone Receptors: An Evolutionary Perspective.

Lin X, Takagi W, Hyodo S, Ijiri S, Katsu Y, Baker M ACS Pharmacol Transl Sci. 2022; 5(2):52-61.

PMID: 35187416 PMC: 8844961. DOI: 10.1021/acsptsci.1c00191.


A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.

Check J, Check D Int J Mol Sci. 2021; 22(22).

PMID: 34830233 PMC: 8621132. DOI: 10.3390/ijms222212351.